Advertisement

Topics

Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin / metformin, Revision: 6, Authorised

09:50 EDT 21 Aug 2017 | European Medicines Agency

This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin / metformin, Revision: 6, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin / metformin, Revision: 6, Authorised"

Advertisement
Quick Search
Advertisement
Advertisement